Charnwood welcomes new partner, medicinal chemist Tom McInally

Charnwood Molecular - Tom McInally final

Charnwood Molecular is pleased to welcome Tom McInally to its group of strategic partners.

Tom has over 30 years’ experience as a medicinal chemist in the pharmaceutical industry at Fisons, Astra Charnwood and AstraZeneca in the UK. He has worked in various therapeutic areas including cardiovascular and respiratory. He led a team which integrated parallel synthesis and purification techniques into in-house LO programmes and subsequently led the chemistry team in a 6 year research collaboration with the Japanese pharmaceutical company DaiNippon Sumitomo to discover novel Toll-Like Receptor 7 agonists targeting various respiratory diseases with a lead compound entering clinical trials.

In 2011 he joined the University of Nottingham as a Business Science Fellow in Medicinal Chemistry. He has taken the lead role in teaching and mentoring 4thyr MSci project students in the principles of medicinal chemistry to enable them to undertake the GSK sponsored drug discovery project entitled “Drug discovery for Fibrotic diseases”.

Tom will work alongside the Medicinal Chemistry team at Charnwood, providing valuable insight and advice on the progress of our current projects.

Share This: